Ajcon Global is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 2400 in its research report dated March 08, 2022.
ICICI Direct is bullish on Ajanta Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 2605 in its research report dated February 02, 2021.
Motilal Oswal is bullish on Ajanta Pharma recommended buy rating on the stock with a target price of Rs 2780 in its research report dated July 30, 2021.
ICICI Direct is bullish on Ajanta Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 2250 in its research report dated May 01, 2021.
Dolat Capital Market is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 2205 in its research report dated April 30, 2021.
Motilal Oswal is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 2030 in its research report dated February 02, 2021.
Dolat Capital Market is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 2208 in its research report dated February 03, 2021.
Anand Rathi is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 1980 in its research report dated November 05, 2020.
Dolat Capital Market recommended accumulate rating on Ajanta Pharma with a target price of Rs 1771 in its research report dated November 05, 2020.
ICICI Direct is bullish on Ajanta Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1960 in its research report dated November 04, 2020.
Dolat Capital recommended accumulate rating on Ajanta Pharma with a target price of Rs 1676 in its research report dated August 01, 2020.
ICICI Direct is bullish on Ajanta Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1810 in its research report dated July 31, 2020.
ICICI Direct is bullish on Ajanta Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1730 in its research report dated May 22, 2020.
Motilal Oswal is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 1700 in its research report dated May 20, 2020.
ICICI Direct recommended hold rating on Ajanta Pharmaceuticals with a target price of Rs 1010 in its research report dated August August 01, 2019.
ICICI Direct recommended hold rating on Ajanta Pharmaceuticals with a target price of Rs 1060 in its research report dated May 02, 2019.
Keynotes Financial Opiniery is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 1080 in its research report dated March 15, 2019.
ICICI Direct recommended hold rating on Ajanta Pharmaceuticals with a target price of Rs 1100 in its research report dated February 01, 2019.
Motilal Oswal is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 1390 in its research report dated January 30, 2019.
ICICI Direct recommended hold rating on Ajanta Pharmaceuticals with a target price of Rs 1190 in its research report dated May 03, 2018.
Spa Research is bullish on Ajanta Pharma has recommended hold rating on the stock with a target price of Rs 1520 in its research report dated February 01, 2018.
For a company on a turnaround journey where the return ratios have started looking up meaningfully, the undemanding valuation at 9X FY19 projected earnings should be looked at seriously by investors
SPA Securities is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 1520 in its research report dated November 09, 2017.
Reliance Securities is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 1500 in its research report dated November 01, 2017.
Motilal Oswal is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 1605 in its research report dated October 12, 2017.